Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
What's new
Get the latest updates from What's new directly as they happen.
Follow now 301 followers
Latest posts
Last updated about 1 hour ago
Human medicines European public assessment report (EPAR): Ivabradine Anpharm, ivabradine, Date of authorisation: 08/09/2015, Revision: 11, Status: Authorised
about 1 hour ago
Human medicines European public assessment report (EPAR): Ivabradine Anpharm, ivabradine, Date of...
Improved scientific advice for medicines for public health threats including antimicrobial resistance
about 1 hour ago
Improved scientific advice for medicines for public health threats including antimicrobial resistance
Scientific advice and protocol assistance
about 1 hour ago
Scientific advice and protocol assistance
Parallel scientific advice and special development aspects or product types
about 1 hour ago
Parallel scientific advice and special development aspects or product types
Scientific advice for public health emergencies and threats
about 1 hour ago
Scientific advice for public health emergencies and threats
Guidance for applicants: the ETF scientific advice that facilitates clinical trial authorisations (SA-CTA)
about 2 hours ago
Guidance for applicants: the ETF scientific advice that facilitates clinical trial authorisations...
Human medicines European public assessment report (EPAR): Corlentor, ivabradine, Date of authorisation: 25/10/2005, Revision: 29, Status: Authorised
about 2 hours ago
Human medicines European public assessment report (EPAR): Corlentor, ivabradine, Date of authorisation...
Human medicines European public assessment report (EPAR): Procoralan, ivabradine, Date of authorisation: 25/10/2005, Revision: 24, Status: Authorised
about 2 hours ago
Human medicines European public assessment report (EPAR): Procoralan, ivabradine, Date of authorisation...
Human medicines European public assessment report (EPAR): Rinvoq, upadacitinib, Date of authorisation: 16/12/2019, Revision: 28, Status: Authorised
about 2 hours ago
Human medicines European public assessment report (EPAR): Rinvoq, upadacitinib, Date of authorisation...
Human medicines European public assessment report (EPAR): Imreplys, sargramostim, Date of authorisation: 21/08/2025, Status: Authorised
about 2 hours ago
Human medicines European public assessment report (EPAR): Imreplys, sargramostim, Date of authorisation...